Antimicrobial peptide (PubMed:23770440, PubMed:27917162, PubMed:27567704). Has a high antibacterial activity against the Gram-positive bacterium S.aureus (MIC=5-17.30 uM), the methicillin-resistant S.aureus (MRSA) (MIC=17.30 uM), and E.faecalis (MIC=69.23 uM) (PubMed:23770440, PubMed:27567704). Has antifungal activity against Candida spp. and one Cryptococcus neoformans strains with MICs values ranging from 6.25 to 100 uM (PubMed:23770440, PubMed:27917162, PubMed:27567704). Shows also an inhibitory activity on C.albicans biofilms at high concentrations (PubMed:27917162).Has a moderate hemolytic potency (18% at 20 uM) (PubMed:23770440, PubMed:27567704). Also inhibits the growth of the five cancer cell lines tested (PubMed:23770440). In the model of polymicrobial sepsis, it exhibits an antibiotic effect, reducing the levels of microorganisms in the infectious focus and the inflammatory responses in the lung and cecum of septic animals (PubMed:27567704). Stable to pH variation. Expressed by the venom gland. The primary structure of the mature peptide is identical to that of NDBP4.23-like from Tityus costatus (AC Q5G8B5). Does not inhibit the Gram-negative bacterium E.coli (PubMed:23770440). Does not show antifungal activity against Candida glabrata (ATCC90030) (MIC>400 uM) (PubMed:27917162). Belongs to the non-disulfide-bridged peptide (NDBP) superfamily. Short antimicrobial peptide (group 4) family.